Supportive Care in Cancer

, Volume 16, Issue 7, pp 763–769 | Cite as

Herbal use among cancer patients during palliative or curative chemotherapy treatment in Norway

  • Silje EngdalEmail author
  • Aslak Steinsbekk
  • Olbjørn Klepp
  • Odd Georg Nilsen
Supportive Care International


Goals of work

This survey aims to explore the differences between cancer patients undergoing chemotherapeutic treatment with palliative or curative intention with respect to concurrent herbal use, experiences of adverse effects, motives of herbal intake, and communication about herbal use with health care providers.

Materials and methods

One hundred and twelve adult cancer patients from the west coast of Central Norway, currently undergoing chemotherapeutic treatment, were recruited to a cross-sectional descriptive survey.

Main results

Palliative and curative patients used herbal remedies concurrent with chemotherapy equally frequent (37% and 38%). One palliative patient reported adverse effects when doubling the dose of injected mistletoe used. Garlic was only used by palliative patients (p = 0.009) who also tended to have a more frequent everyday herbal use (78% vs 67%, respectively) than curative patients (p = 0.075). Curative patients, however, used herbal remedies more often to counteract adverse reactions (31% vs 3%, respectively; p = 0.026). A bivariate logistic regression, which was adjusted for age, showed that palliative patients used herbal remedies more frequently to improve their immune system (adjusted OR = 7.5, 95% CI = 1.1–49.7).


This is the first survey comparing concurrent herbal use between cancer patients undergoing palliative or curative chemotherapy. Both groups frequently use herbal remedies concurrent with chemotherapy, but with a slightly different intent. The frequent concurrent use emphasizes the need for clinicians to include questions on complementary and alternative medicine in routine history taking and for further studies on possible herb–drug interactions among the cancer patient.


Neoplasms Medicinal herbs Chemotherapy Palliative Curative 



We wish to thank the nurses and patients at the Department of Oncology at Sunnmøre Public Hospital Enterprise, Ålesund Ward and Volda Ward. This research was founded by the Norwegian Cancer Society.


  1. 1.
    Boon HS, Olatunde F, Zick SM (2007) Trends in complementary/alternative medicine use by breast cancer survivors: comparing survey data from 1998 and 2005. BMC Womens Health 7:4PubMedCrossRefGoogle Scholar
  2. 2.
    Eisenberg DM, Davis RB, Ettner SL, Appel S, Wilkey S, Van RM, Kessler RC (1998) Trends in alternative medicine use in the United States, 1990–1997: results of a follow-up national survey. JAMA 280:1569–1575PubMedCrossRefGoogle Scholar
  3. 3.
    Ernst E, Cassileth BR (1998) The prevalence of complementary/alternative medicine in cancer: a systematic review. Cancer 83:777–782PubMedCrossRefGoogle Scholar
  4. 4.
    Giveon SM, Liberman N, Klang S, Kahan E (2003) A survey of primary care physicians’ perceptions of their patients’ use of complementary medicine. Complement Ther Med 11:254–260PubMedCrossRefGoogle Scholar
  5. 5.
    Giveon SM, Liberman N, Klang S, Kahan E (2004) Are people who use “natural drugs” aware of their potentially harmful side effects and reporting to family physician. Patient Educ Couns 53:5–11PubMedCrossRefGoogle Scholar
  6. 6.
    Hall SD, Wang Z, Huang SM, Hamman MA, Vasavada N, Adigun AQ, Hilligoss JK, Miller M, Gorski JC (2003) The interaction between St John’s wort and an oral contraceptive. Clin Pharmacol Ther 74:525–535PubMedCrossRefGoogle Scholar
  7. 7.
    Howat A, Veitch C, Cairns W (2006) A descriptive study comparing health attitudes of urban and rural oncology patients. Rural Remote Health 6:563PubMedGoogle Scholar
  8. 8.
    Humpel N, Jones SC (2006) Gaining insight into the what, why and where of complementary and alternative medicine use by cancer patients and survivors. Eur J Cancer Care 15:362–368CrossRefGoogle Scholar
  9. 9.
    Hyodo I, Amano N, Eguchi K, Narabayashi M, Imanishi J, Hirai M, Nakano T, Takashima S (2005) Nationwide survey on complementary and alternative medicine in cancer patients in Japan. J Clin Oncol 23:2645–2654PubMedCrossRefGoogle Scholar
  10. 10.
    Lee MM, Lin SS, Wrensch MR, Adler SR, Eisenberg D (2000) Alternative therapies used by women with breast cancer in four ethnic populations. J Natl Cancer Inst 92:42–47PubMedCrossRefGoogle Scholar
  11. 11.
    Maher EJ, Mackenzie C, Young T, Marks D (1996) The use of the Hospital Anxiety and Depression Scale (HADS) and the EORTC QLQ-C30 questionnaires to screen for treatable unmet needs in patients attending routinely for radiotherapy. Cancer Treat Rev 22(Suppl A):123–129PubMedCrossRefGoogle Scholar
  12. 12.
    McCune JS, Hatfield AJ, Blackburn AAR, Leith PO, Livingston RB, Ellis GK (2004) Potential of chemotherapy–herb interactions in adult cancer patients. Support Care Cancer 12:454–462PubMedCrossRefGoogle Scholar
  13. 13.
    Molassiotis A, Fernadez-Ortega P, Pud D, Ozden G, Scott JA, Panteli V, Margulies A, Browall M, Magri M, Selvekerova S, Madsen E, Milovics L, Bruyns I, Gudmundsdottir G, Hummerston S, Ahmad AM, Platin N, Kearney N, Patiraki E (2005) Use of complementary and alternative medicine in cancer patients: a European survey. Ann Oncol 16:655–663PubMedCrossRefGoogle Scholar
  14. 14.
    Ohlen J, Balneaves LG, Bottorff JL, Brazier ASA (2006) The influence of significant others in complementary and alternative medicine decisions by cancer patients. Soc Sci Med 63:1625–1636PubMedCrossRefGoogle Scholar
  15. 15.
    Richardson MA, Sanders T, Palmer JL, Greisinger A, Singletary SE (2000) Complementary/alternative medicine use in a comprehensive cancer center and the implications for oncology. J Clin Oncol 18:2505–2514PubMedGoogle Scholar
  16. 16.
    Risberg T, Kolstad A, Bremnes Y, Holte H, Wist EA, Mella O, Klepp O, Wilsgaard T, Cassileth BR (2004) Knowledge of and attitudes toward complementary and alternative therapies: a national multicentre study of oncology professionals in Norway. Eur J Cancer 40:529–535PubMedCrossRefGoogle Scholar
  17. 17.
    Timmermans LM, van der Maazen RW, Leer JW, Kraaimaat FW (2006) Palliative or curative treatment intent affects communication in radiation therapy consultations. Psycho-oncology 15:713–725PubMedCrossRefGoogle Scholar
  18. 18.
    Wilkinson S, Aldridge J, Salmon I, Cain E, Wilson B (1999) An evaluation of aromatherapy massage in palliative care. Palliat Med 13:409–417PubMedCrossRefGoogle Scholar
  19. 19.
    World Health Organization (2005) National policy on traditional medicine and regulation of herbal medicines—report of a WHO global survey. World Health Organization, Geneva, p 1Google Scholar
  20. 20.
    Yates JS, Mustian KM, Morrow GR, Gillies LJ, Padmanaban D, Atkins JN, Issell B, Kirshner JJ, Colman LK (2005) Prevalence of complementary and alternative medicine use in cancer patients during treatment. Support Care Cancer 13:806–811PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2007

Authors and Affiliations

  • Silje Engdal
    • 1
    Email author
  • Aslak Steinsbekk
    • 2
  • Olbjørn Klepp
    • 3
  • Odd Georg Nilsen
    • 1
  1. 1.Department of Cancer Research and Molecular Medicine, Faculty of MedicineNorwegian University of Science and Technology (NTNU), Medical Technical Research CentreTrondheimNorway
  2. 2.Department of Public Health and General Practice, Faculty of MedicineNorwegian University of Science and Technology (NTNU)TrondheimNorway
  3. 3.Department of OncologySunnmøre Public Hospital Enterprise, Ålesund HospitalÅlesundNorway

Personalised recommendations